LIGAND PHARMACEUTICALS (LGND) Stock Cash Flow
NASDAQ:LGND - Nasdaq - US53220K5048 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -132.62M | -4.03M | 52.15M | -33.40M | 57.10M | |||
| Depreciation Amortization | 35.00M | 35.00M | 37.00M | 51.50M | 51.10M | |||
| Income Taxes - Deferred | -44.19M | -15.80M | 11.70M | 20.70M | -8.60M | |||
| Change In Working Capital | 5.51M | 19.00M | -34.00M | 65.70M | -52.20M | |||
| Interest Paid | 300.00K | 260.00K | 290.00K | 1.40M | 3.00M | |||
| Taxes Paid | N/A | 19.00M | 8.77M | 11.60M | 3.70M | |||
| Other non cash items | 188.00M | 62.00M | -16.00M | 33.30M | 31.40M | |||
| OPERATING CASH FLOW | 52.00M | 97.00M | 50.00M | 137.90M | 78.80M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.92M | -1.82M | -64.00M | -17.90M | -8.80M | |||
| Other Investing Activity | -133.22M | -142.00M | 53.00M | 181.50M | 39.30M | |||
| INVESTING CASH FLOW | -135.33M | -144.00M | -12.00M | 163.60M | 30.50M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -30.00K | -30.00K | -77.00M | -261.00M | -164.90M | |||
| Stock Issued/Repurchased | 92.22M | 103.00M | 22.00M | 3.20M | 15.30M | |||
| Other Financing Activity | -11.40M | -5.56M | -5.50M | -18.20M | 11.90M | |||
| FINANCING CASH FLOW | 80.25M | 97.00M | -60.00M | -276.00M | -137.80M | |||
| Exchange Rate Effect | N/A | -1.17M | N/A | N/A | 0.00 | |||
| CHANGE IN CASH | -3.19M | 48.83M | -22.00M | 25.50M | -28.50M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 52.00M | 97.00M | 50.00M | 137.90M | 78.80M | |||
| Capital Expenditure | -1.92M | -1.82M | -64.00M | -17.90M | -8.80M | |||
| FREE CASH FLOW | 50.08M | 95.18M | -14.00M | 120.00M | 70.00M | |||
All data in USD